GUGGENHEIM CAPITAL LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 243 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 4.76 and the average weighting 0.3%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$411,051
-21.5%
6,860
-5.6%
0.00%0.0%
Q2 2023$523,735
+2.9%
7,264
+5.0%
0.00%0.0%
Q1 2023$509,036
+19.5%
6,920
+8.5%
0.00%0.0%
Q4 2022$425,850
-15.7%
6,375
+8.8%
0.00%
-20.0%
Q3 2022$505,000
+107.8%
5,861
+115.8%
0.01%
+150.0%
Q2 2022$243,000
-89.2%
2,716
-88.5%
0.00%
-87.5%
Q3 2020$2,255,000
-14.5%
23,655
+0.4%
0.02%
-20.0%
Q2 2020$2,636,000
+57.6%
23,563
+2.4%
0.02%
+17.6%
Q1 2020$1,673,000
-38.3%
23,009
-11.6%
0.02%
-15.0%
Q4 2019$2,713,000
+26.4%
26,015
+20.7%
0.02%
+17.6%
Q3 2019$2,146,000
-21.6%
21,562
-10.1%
0.02%
-22.7%
Q2 2019$2,736,000
-17.9%
23,972
-9.6%
0.02%
-18.5%
Q1 2019$3,334,000
-22.2%
26,519
-16.0%
0.03%
-25.0%
Q4 2018$4,284,000
-41.0%
31,569
+19.4%
0.04%
-23.4%
Q3 2018$7,258,000
+52.5%
26,442
+15.1%
0.05%
+46.9%
Q2 2018$4,758,000
-19.1%
22,967
-35.5%
0.03%
+128.6%
Q1 2018$5,880,000
+13.8%
35,613
-5.6%
0.01%
+16.7%
Q4 2017$5,166,000
-3.3%
37,728
-3.9%
0.01%
-7.7%
Q3 2017$5,342,000
+17.3%
39,243
+4.6%
0.01%
+8.3%
Q2 2017$4,556,000
+14.4%
37,531
-0.2%
0.01%
+9.1%
Q1 2017$3,982,000
+6.2%
37,604
+1.9%
0.01%0.0%
Q4 2016$3,751,000
-41.4%
36,914
-41.2%
0.01%
-45.0%
Q3 2016$6,405,000
-18.6%
62,762
-4.9%
0.02%
-20.0%
Q2 2016$7,869,000
+1.8%
65,974
-8.6%
0.02%
+4.2%
Q1 2016$7,728,000
-24.2%
72,163
-23.3%
0.02%
-20.0%
Q4 2015$10,198,000
+22.3%
94,060
-3.4%
0.03%
+15.4%
Q3 2015$8,341,000
-29.8%
97,393
-17.3%
0.03%
-10.3%
Q2 2015$11,883,000
+41.9%
117,778
+8.4%
0.03%
+45.0%
Q1 2015$8,377,000
+44.2%
108,642
-0.5%
0.02%
+33.3%
Q4 2014$5,810,000
+16.2%
109,187
+2.6%
0.02%
+25.0%
Q3 2014$5,002,000
+23.9%
106,428
+64.2%
0.01%
+20.0%
Q2 2014$4,036,000
-20.3%
64,800
-14.0%
0.01%
-28.6%
Q1 2014$5,067,000
+12.1%
75,328
-12.4%
0.01%0.0%
Q4 2013$4,522,00085,9760.01%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Knott David M Jr 115,000$8,4593.32%
VILLERE ST DENIS J & CO LLC 480,807$35,368,1622.57%
Chicago Capital, LLC 449,508$33,065,8221.64%
RICE HALL JAMES & ASSOCIATES, LLC 288,345$21,210,6811.20%
Smith, Graham & Co., Investment Advisors, LP 65,163$4,793,3900.58%
Stephens Investment Management Group LLC 455,089$33,476,3470.56%
CARDINAL CAPITAL MANAGEMENT LLC /CT 201,993$14,858,6050.53%
WOODSTOCK CORP 52,604$3,869,5500.49%
Court Place Advisors, LLC 15,533$1,142,6070.41%
Jackson Creek Investment Advisors LLC 12,726$9360.39%
View complete list of LIGAND PHARMACEUTICALS INC shareholders